Literature DB >> 19125313

Immunosuppressive activity of mesenchymal stem cells is not decreased in children with aplastic anemia.

Yinyan Xu1, Yoshiyuki Takahashi1, Ayami Yoshimi1, Makito Tanaka1, Hiroshi Yagasaki1, Seiji Kojima2.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19125313     DOI： 10.1007/s12185-008-0237-6

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  5 in total

1.  T-cell suppression mediated by mesenchymal stem cells is deficient in patients with severe aplastic anemia.

Authors:  Andrea Bacigalupo; Marisa Valle; Marina Podestà; Anna Pitto; Elena Zocchi; Antonio De Flora; Sara Pozzi; Silvia Luchetti; Francesco Frassoni; Maria Teresa Van Lint; Giovanna Piaggio
Journal:  Exp Hematol       Date:  2005-07       Impact factor: 3.084

Review 2.  The pathophysiology of acquired aplastic anemia.

Authors:  N S Young; J Maciejewski
Journal:  N Engl J Med       Date:  1997-05-08       Impact factor: 91.245

3.  Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo.

Authors:  Amelia Bartholomew; Cord Sturgeon; Mandy Siatskas; Karen Ferrer; Kevin McIntosh; Sheila Patil; Wayne Hardy; Steve Devine; David Ucker; Robert Deans; Annemarie Moseley; Ronald Hoffman
Journal:  Exp Hematol       Date:  2002-01       Impact factor: 3.084

4.  Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli.

Authors:  Massimo Di Nicola; Carmelo Carlo-Stella; Michele Magni; Marco Milanesi; Paolo D Longoni; Paola Matteucci; Salvatore Grisanti; Alessandro M Gianni
Journal:  Blood       Date:  2002-05-15       Impact factor: 22.113

5.  Aplastic anaemia: Evidence for an immunological mechanism.

Authors:  J Ascensão; R Pahwa; W Kagan; J Hansen; M Moore; R Good
Journal:  Lancet       Date:  1976-03-27       Impact factor: 79.321
  5 in total
  4 in total

Review 1.  The complex pathophysiology of acquired aplastic anaemia.

Authors:  Y Zeng; E Katsanis
Journal:  Clin Exp Immunol       Date:  2015-04-23       Impact factor: 4.330

2.  Human Acquired Aplastic Anemia Patients' Bone-Marrow-Derived Mesenchymal Stem Cells Are Not Influenced by Hematopoietic Compartment and Maintain Stemness and Immune Properties.

Authors:  Vandana Sharma; Sonali Rawat; Suchi Gupta; Sweta Tamta; Rinkey Sharma; Tulika Seth; Sujata Mohanty
Journal:  Anemia       Date:  2021-04-29

Review 3.  Mesenchymal stem cells in immune-mediated bone marrow failure syndromes.

Authors:  Maria-Christina Kastrinaki; Konstantia Pavlaki; Aristea K Batsali; Elisavet Kouvidi; Irene Mavroudi; Charalampos Pontikoglou; Helen A Papadaki
Journal:  Clin Dev Immunol       Date:  2013-12-10

Review 4.  Yin and Yang of mesenchymal stem cells and aplastic anemia.

Authors:  Larisa Broglie; David Margolis; Jeffrey A Medin
Journal:  World J Stem Cells       Date:  2017-12-26       Impact factor: 5.247
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.